Imeik Technology Development Co (300896)

Currency in CNY
81.09
-2.88(-3.43%)
Closed·
Advertisement
Trading near 52-week Low
300896 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
80.8384.28
52 wk Range
80.83158.80
Key Statistics
Bid/Ask
81.09 / 81.24
Prev. Close
81.09
Open
83.61
Day's Range
80.83-84.28
52 wk Range
80.83-158.8
Volume
2.61M
Average Volume (3m)
2.64M
1-Year Change
-45.2095%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300896 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
118.58
Upside
+46.24%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

7 Buy
3 Hold
1 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 118.58
(+46.24% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Nomura/Instinet
Hold94.09+16.03%101.30Maintain12/11/2026
Macquarie
Buy117.00+44.28%125.00Maintain29/10/2026
Nomura/Instinet
Hold101.30+24.92%123.90Maintain27/08/2026
Macquarie
Buy125.00+54.15%149.10Maintain24/08/2026
Nomura/Instinet
Hold123.90+52.79%-New Coverage01/04/2026

Earnings

Latest Release
29/10/2026
EPS / Forecast
0.65 / 0.96
Revenue / Forecast
528M / 644.58M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.27
Dividend Yield
3.57%
Industry Median 1.88%
Annualised payout
3.00
Paid annually
5-Years Growth
+5.32%
Growth Streak

Imeik (300896) Income Statement & Profits

Compare 300896 to Peers and Sector

Metrics to compare
300896
Peers
Sector
Relationship
P/E Ratio
24.7x46.5x−0.2x
PEG Ratio
−0.750.440.00
Price/Book
3.1x2.4x2.6x
Price / LTM Sales
10.5x7.6x2.6x
Upside (Analyst Target)
46.2%43.7%77.0%
Fair Value Upside
Unlock10.5%13.7%Unlock

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; and skin care products. It serves medical aesthetic institutions. The company was incorporated in 2004 and is headquartered in Beijing, China.

Employees
1458
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
29.51M9.79%2.39B
Other Institutional Investors
41.87M13.89%3.40B
Public Companies & Retail Investors
230.04M76.32%18.65B
Total
301.43M100.00%24.44B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Xiamen Zhixin Junxing Investment Partnership Enterprise (Limited Partnership)6.45%19,428,1421,575,428
Xiamen Danrui Investment Partnership Enterprise (Limited Partnership)4.87%14,679,0411,190,323

People Also Watch

38.50
300759
-3.39%
47.22
001280
-3.97%
21.04
000792
-1.82%
30.40
300765
-5.21%
6.19
000983
-2.06%

FAQ

What Is the Imeik (Shenzhen: 300896) Share Price Today?

The Imeik stock price today is 81.09 CNY.

What Stock Exchange Does Imeik (300896) Trade On?

Imeik is listed and trades on the Shenzhen Stock Exchange.

What Is the Ticker (Stock Symbol) for Imeik?

The stock symbol (also called a 'ticker') for Imeik is "300896."

Does Imeik Pay Dividends? What’s The Current 300896 Dividend Yield?

Yes, 300896 Pays Dividends to its Shareholders. The current Imeik dividend yield is 3.6%%.

What Is the Current Imeik Market Capitalisation?

As of today, Imeik (Shenzhen: 300896) market cap is 24.44B CNY.

What Is Imeik's (300896) Earnings Per Share (TTM)?

The Imeik EPS is currently 3.27 (Trailing Twelve Months).

When Is the Next Imeik Earnings Date?

Imeik's next earnings report will be released on 10/03/2027.

Is 300896 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Imeik moving averages and other technical indicators, the daily buy/sell signal for 300896 stock is Strong Sell.

How Many Times Has Imeik Stock Split?

Imeik has split 2 times. (See the 300896 stock split history page for full effective split date and price information.)

How Many Employees Does Imeik Have?

Imeik has 1458 employees, based on their latest Companies House report.

What is the current trading status of Imeik (Shenzhen: 300896)?

As of 22/11/2026, Imeik (300896) is trading at a share price of 81.09 CNY, with a previous close of 81.09 CNY. The stock has fluctuated within a day range of 80.83 CNY to 84.28 CNY, while its 52-week range spans from 80.83 CNY to 158.80 CNY.

What Is Imeik (300896) Price Target According to Analysts?

The average 12-month price target for Imeik is 118.58 CNY, with a high estimate of 145 CNY and a low estimate of 91 CNY. 7 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +46.24% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.